XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375 — États financiers (NASDAQ:XOMAO) | MetaTrader

Afficher le graphique complet

Nouvelles

H.C. Wainwright abaisse la note de l’action XOMA suite à l’acquisition par Ligand

La notation de l’action Xoma rétablie à "Conserver" par TD Cowen après l’acquisition de Generation Bio

Xoma stock rating reinstated as Hold by TD Cowen after Generation Bio acquisition

XOMA Royalty finalise l’acquisition de Generation Bio ; GBIO retiré du NASDAQ

XOMA Royalty completes acquisition of Generation Bio; GBIO delisted from Nasdaq

I’m Staying Neutral On XOMA After The LAVA And HilleVax Deals (NASDAQ:XOMA)

Collect Up To 11.5% From The Healthcare Sector

XOMA Royalty’s Preferreds Still Offer Attractive Yields With A Biotech Twist (XOMA)